News
Filters
Showing 1 - 7 out of 7 results
News
Strokes During Commute Turned MoBap Provider Into Grateful Patient
Last year, Michelle Mick was driving, minutes away from Missouri Baptist Medical Center, when she encountered an odd and uncomfortable sensation.
Article
Who Should Get Screened for Lung Cancer?
Lung cancer screenings have been shown to reduce deaths by 20%-30% in high-risk populations. Learn about who should be screened as well as what to expect during the scan.
Article
Witnessing a breakthrough: physicians find hope in new Alzheimer’s drug
For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.
But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.
Patient Story
Restoring Hope: How a Breakthrough Treatment Helped a Teenager Defeat Epilepsy
Sophia suffered from epilepsy that for years disrupted her life and put severe limitations on her future. But after receiving a groundbreaking procedure from the pediatric neurology team at St. Louis Children’s Hospital, Sophia, now 18, is seizure free.
Article
Noticing the Signs and Symptoms of Stroke Can Help Save a Life
Nearly 800,000 Americans suffer from stroke every year, according to the American Stroke Association, making stroke the fifth-leading cause of death in the United States.
Article
How can you reduce your risk of lung cancer?
Prioritizing lung health during lung cancer awareness month
New lung cancer screening guidelines mean more at-risk patients can now be screened
The Centers for Medicare and Medicaid recently adopted new guidelines for lung cancer screening, changing the age at which men and women should start screening and expanding criteria for smoking history.